BioVendor Laboratory Medicine

BioVendor Laboratory Medicine is a leading international biotechnology company based in the Czech Republic, specializing in the development, manufacture, and distribution of in vitro diagnostics (IVD) and research-use products. As the flagship of the BioVendor Group, the company offers an extensive portfolio of ELISA kits, recombinant proteins, antibodies, and molecular diagnostic reagents. They are globally recognized for their innovation in microRNA quantification through their proprietary miREIA technology and their fully automated CLIA (Chemiluminescence Immunoassay) platform. The company focuses on high-value niche biomarkers in therapeutic areas such as endocrinology, oncology, cardiology, and infectious diseases. BioVendor serves a diverse clientele including clinical laboratories, hospitals, and academic research institutions across more than 100 countries. With a strong commitment to research and development, the company maintains strategic partnerships with leading academic centers to translate novel biomarkers into clinical practice.